CHIESI FARMACEUTICI S.P.A.
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- -
- Established
- 1935-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.chiesigroup.com
Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years Old
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-11-09
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 26
- Registration Number
- NCT01468272
- Locations
- 🇩🇰
BørneAstmaKlinikken, Hans Knudsens Plads 1A,, Copenhagen,, Denmark
Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-10-12
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 72
- Registration Number
- NCT01450774
- Locations
- 🇩🇰
BørneAstmaKlinikken, Copenhagen, Denmark
Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-08-22
- Last Posted Date
- 2014-02-06
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 74
- Registration Number
- NCT01421056
- Locations
- 🇺🇸
Memory Center of New Jersey, Inc., Monroe Twp, New Jersey, United States
🇮🇹Osp. Niguarda Ca'Granda, Dip. Di Neuroscienze, Milano, Italy
🇺🇸Memory Enhancement Center of NJ, Inc., Toms River, New Jersey, United States
Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-07-20
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 44
- Registration Number
- NCT01398111
- Locations
- 🇧🇪
Clinical Pharmacology Unit - SGS Life Science Services, Antwerpen, Lange Beeldekensstraat 267, Belgium
Pilot Pharmacokinetic Clenil Study With AeroChamber Plus™ or Volumatic™ Spacer Devices
- First Posted Date
- 2011-06-09
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 16
- Registration Number
- NCT01370031
- Locations
- 🇬🇧
Medicines Evaluation Unit, Wythenshawe Hospital, Manchester, United Kingdom
A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR)
Phase 3
Terminated
- Conditions
- Interventions
- First Posted Date
- 2011-05-11
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 113
- Registration Number
- NCT01351792
- Locations
- 🇳🇱
Department of Pulmonary Diseases - University Medical Center Groningen, Groningen, Netherlands
Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI
Phase 2
Completed
- Conditions
- First Posted Date
- 2011-05-06
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 24
- Registration Number
- NCT01349257
- Locations
- 🇬🇧
Medicines Evaluation Unit Ltd, Manchester, United Kingdom
Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-05-05
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 260
- Registration Number
- NCT01348243
- Locations
- 🇮🇹
Policlinico GB Rossi, Verona, Italy
Efficacy of CHF1535 Via NEXT DPI Versus pMDI and BDP DPI100µg on PeakExpiratoryFlow in Asthmatic Patients
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-05-02
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 932
- Registration Number
- NCT01345916
- Locations
- 🇵🇱
GSPZOZ Uniwersytecki Szpital Kliniczny, Łódź, Poland
Study to Investigate the Effect of Formoterol vs Salmeterol on Small Airways Physiological Parameters in COPD Patients
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-04-29
- Last Posted Date
- 2017-03-30
- Lead Sponsor
- Chiesi Farmaceutici S.p.A.
- Target Recruit Count
- 16
- Registration Number
- NCT01344655
- Locations
- 🇬🇧
Airway Disease Section, NHLI, Imperial College London, London, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath